{
    "organizations": [],
    "uuid": "f0c12c02a3bd6e9ca4bee95a56ceffc26c992b0f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aimmune-therapeutics-announces-pri/brief-aimmune-therapeutics-announces-pricing-of-public-offering-of-common-stock-idUSASB0C6V8",
    "ord_in_thread": 0,
    "title": "BRIEF-Aimmune Therapeutics Announces Pricing Of Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - Aimmune Therapeutics Inc:\n* AIMMUNE THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK\n* AIMMUNE THERAPEUTICS- ANNOUNCED ‍PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 5.5 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $32.00/SHARE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T09:00:00.000+02:00",
    "crawled": "2018-02-22T03:29:02.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "aimmune",
        "therapeutic",
        "inc",
        "aimmune",
        "therapeutic",
        "announces",
        "pricing",
        "public",
        "offering",
        "common",
        "stock",
        "aimmune",
        "announced",
        "underwritten",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "price",
        "public",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}